Signature requirements for delivery of prescribed medications during COVID-19
Effective 03/31/2020, The Health Care Authority is temporarily removing the requirement to obtain a signature from the Medicaid client or the client’s designee upon receipt of pharmacy products dispensed and delivered directly to a client. In response to the current public health emergency surrounding the outbreak of the Coronavirus disease (COVID-19), along with the Governor of Washington’s emergency proclamations related to COVID-19, Washington Administrative Code 182-530-5000(e)(i) has been updated to allow delivery of pharmacy products without signature from the client or the client’s designee in order to avoid unnecessary contact between the client and the delivery person.
Any state and federal rules related to signature requirements for scheduled drugs remain in effect unless separately waived by the Washington State Department of Health and/or federal Food and Drug Administration.
|